Search

everythinglearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

The cream effectively and safely reduces facial hair in women.

The combination of encorafenib and binimetinib caused few skin issues.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ectodysplasin inhibits Wnt signaling to help form hair follicles.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Blocking interferon-gamma might help treat various autoimmune diseases.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib taken by mouth helps treat hair loss in children.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Nano-liposome-bound EGF can delay hair growth in rats.

XEDAR triggers a specific signaling pathway in cells.